Norway pharmacy online: Kjøp av viagra uten resept i Norge på nett.

Jeg kan anbefale en god måte for å øke potens - Cialis. Fungerer mye bedre kjøp viagra Alltid interessant, disse pillene og andre ting i Generelle virkelig har helse til å handle.

User manual-enz-51034-k500 - lyso-id™ green lysosomal detection kit-rev. 1.0 may

Enabling Discovery in Life Science®
Lyso-ID® Green Detection Kit
for microscopy

Instruction Manual

Cat. No. ENZ-51034-K500
500 assays

For research use only.
Notice to Purchaser
The Lyso-ID® Green Detection Kit is a member of the CELLestial® product line, reagents and assay kits comprising fluorescent molecular probes that have been exten-sively benchmarked for live cell analysis applications. CELLestial® reagents and kits are optimal for use in demanding cell analysis applications involving confocal microscopy, flow cytometry, microplate readers and HCS/HTS, where consistency and reproducibility are required. This product is manufactured and sold by ENZO LIFE SCIENCES, INC. for research use only by the end-user in the research market and is not intended for diagnostic or therapeutic use. Purchase does not include any right or license to use, develop or otherwise exploit this product commercially. Any commercial use, development or exploitation of this product or development using this product without the express prior written authorization of ENZO LIFE SCIENCES, INC. is strictly prohibited. Limited Warranty
These products are offered under a limited warranty. The products are guaranteed to meet appropriate specifications described in the package insert at the time of shipment. Enzo Life Sciences’ sole obligation is to replace the product to the extent of the purchase price. All claims must be made to Enzo Life Sciences, Inc. within five (5) days of receipt of order. Trademarks and Patents
Enzo, CELLestial, and Lyso-ID are trademarks of Enzo Life Sciences, Inc. Lysotracker is a trademark of Molecular Probes. Several of Enzo’s products and product applications are covered by US and foreign patents and patents pending. Contents
Introduction . 1
Provided and Storage. 2
Materials Required . 2
IV. Safety Warnings and Precautions . 2
Procedures . 3
D. Staining Live Cells Grown in Suspension . 5 Appendices
VII. References
VIII. Troubleshooting Guide . 7
I. Introduction
Enzo Life Sciences’ Lyso-ID® Green Detection Kit contains a novel acidic organelle-selective dye suitable for live-cell staining. Conventional fluores-cent stains for acidic organelles, such as Acridine Orange (Catalog No. ENZ-52405), form metachromatic artifacts that interfere with multicolor imaging applications. Lyso-ID® Green dye generates emission profiles that can be multiplexed with other fluorophores. The dye accumulates in acidic compartments, such as endosomes, lysosomes, and secretory vesicles. Low micromolar concentrations of Lyso-ID® Green dye are sufficient for staining mammalian cells. This has been validated with the human cervical carcinoma cell line, HeLa, the human T-lymphocyte cell line, Jurkat, and the human bone osteosarcoma epithelial cell line, U2OS. One important application of Lyso-ID® Green dye is in fluorescence co-localization imaging with red fluorescent protein (RFP)-tagged proteins. This is a powerful approach for determining the targeting of molecules to intracellular compartments, and for screening of associations and interac-tions between these molecules. For example, dual-color fluorescence detection may be employed for the identification of vesicular compartments and the investigation of their dynamics and fusion during exocytosis. However, metachromatic artifacts wherein fluorescent dyes emit both in the red and green regions of the spectrum compromise such analyses, as observed with Acridine Orange dye. These observations have led to spurious results in fluorescent protein co-localization experiments.(1, 2) Additionally, many organelle-targeting probes photobleach rapidly, are subject to quenching when concentrated in organelles, are highly toxic, or only transiently associate with the target organelle, requiring imaging within a minute or two of dye addition.(3, 4) The Lyso-ID® Green dye, a new green-emitting, cell-permeable small organic probe molecule that spontaneously localizes to live cell acidic organelles, was developed to overcome the above problems. It can be readily used in combination with other common UV and visible light excit-able fluorescent dyes and various fluorescent proteins in multicolor imaging and detection applications. The Lyso-ID® Green dye is suitable for both short-term and long-term tracking studies. It emits in the FITC region of the visible light spectrum, and is highly resistant to photobleaching, concentra-tion quenching and photoconversion. The Lyso-ID® Green Detection Kit is specifically designed for use with RFP-expressing cell lines, as well as cells expressing blue, cyan or orange fluorescent proteins (BFPs, CFPs, OFPs). A lysosome perturbation agent, chloroquine, is provided as a positive control for monitoring changes in lysosome number and volume. A nuclear counterstain is also provided in the kit to highlight this organelle as well. II. Reagents Provided and Storage
All reagents are shipped on dry ice. Upon receipt, the kit should be stored at ≤-20°C, protected from light.  When stored properly, these reagents are stable for at least twelve months. Avoid repeated freezing and thawing.
Reagents provided in the kit are sufficient for approximately 500 assays using either live, adherent cells or cells in suspension. Quantity
III. Additional Materials Required
 Standard fluorescence microscope  Calibrated, adjustable precision pipetters, preferably with disposable  Adjustable speed centrifuge with swinging buckets (for suspension  Glass microscope slides  Glass cover slips  Deionized water  Anhydrous DMSO (optional)  Growth medium (e.g., Dulbecco’s Modified Eagle Medium, D-MEM) IV. Safety Warnings and Precautions
 This product is for research use only and is not intended for diagnostic  The Lyso-ID® Green Detection Reagent contains DMSO which is read-
ily absorbed through the skin. It is harmful if ingested or absorbed through the skin and may cause irritation to the eyes. Observe appro-priate precautions when handling.  Reagents should be treated as possible mutagens and should be handled with care and disposed of properly.  Observe good laboratory practices. Gloves, lab coat, and protective eyewear should always be worn. Never pipet by mouth. Do not eat, drink or smoke in the laboratory areas. All blood components and biological materials should be treated as potentially hazardous and handled as such. They should be disposed of in accordance with established safety procedures.  To avoid photobleaching, perform all manipulations in low light environments or protected from light by other means. V. Methods and Procedures
NOTE: Allow all reagents to thaw at room temperature before starting with the
procedures. Upon thawing, gently hand-mix or vortex the reagents prior to use to ensure a homogenous solution. Briefly centrifuge the vials at the time of first use, as well as for all subsequent uses, to gather the contents at the bottom of the tube. A. REAGENT
1. Positive Control
Chloroquine is a lysosomotropic agent. It accumulates preferen-tially in the lysosomes of cells.5 The pKa for the quinoline nitrogen of chloroquine is approximately 8.5. At physiological pH, it is roughly 10% deprotonated as calculated using the Henderson-Hasselbalch equation. This decreases to roughly 0.2% at a lysosomal pH of 4.6. Since the deprotonated form of the compound is more membrane permeable than the protonated form, chloroquine becomes quantitatively "trapped" in lysosomes. The chloroquine provided in the kit may be used as a positive control for increasing lysosome number and volume. It is supplied lyophilized (7.5 µmoles) and should be centrifuged briefly to gather the material at the bottom of the tube. Reconstitute the lyophilized material in 125 μL deionized water for a 60 mM stock solution. It is recommended that treatment with the agent be performed using 10-300 μM final concentration in order to observe changes in lysosomal morphology. Unused stock chloroquine may be stored in small aliquots at -20°C for several weeks. 2. 1X Assay Buffer
Allow the 10X Assay Buffer to warm to room temperature. Make sure that the reagent is free of any crystallization before dilution. Prepare enough 1X Assay Buffer for the number of samples to be assayed by diluting each milliliter (mL) of the 10X Assay Buffer with 9 mL of deionized water. 3. Dual Detection Reagent
The concentration of Lyso-ID® Green dye for optimal staining will vary depending upon the application. Suggestions are provided to use as guidelines, though some modifications may be required depending upon the particular cell type employed and other factors such as the permeability of the dye to the cells or tissues.   To reduce potential artifacts from overloading of the cells, the concentration of the dye should be kept as low as possible. Prepare sufficient amount of Dual Detection Reagent for the number of samples to be assayed as follows: To each milliliter of 1X Assay Buffer (see preparation in step 2) or cell culture medium, add 1 µL of Lyso-ID® Green Detection Reagent and 1 µL of Hoechst 33342 Nuclear Stain. Serum may be included, if preferred. NOTE: (a) The dyes may be combined into one staining solution or
each may be used separately, if desired. (b) The Hoechst 33342 Nuclear Stain can be diluted further if its staining intensity is much stronger than the green lysosomal stain, Lyso-ID® Green. (c) When staining BFP- or CFP-expressing cells, the Hoechst 33342 Nuclear Stain should be omitted due to its spectral overlap with these fluorescent proteins. PREPARATIONS
Cells should be maintained via standard tissue culture practices. Positive control cells should be pretreated with the chloroquine con-trol for 2-8 hours. Response to chloroquine is time and concentration dependent and may also vary significantly depending upon cell type and cell line. Negative control cells should be treated with a vehicle (DMSO, media or other solvent used to reconstitute or dilute an inducer or inhibitor) for an equal length of time under similar conditions. C. STAINING LIVE, ADHERENT CELLS
1. Grow cells on cover slips inside a Petri dish filled with the appro- priate culture medium. When the cells have reached the desired level of confluence, carefully remove the medium. 2. Dispense sufficient volume of Dual Detection Reagent (see section V-A3, page 3) to cover the monolayer cells (~100 μL of labeling solution for cells grown on an 18 X 18 mm coverslip). 3. Protect samples from light and incubate for 30 minutes at 37°C. 4. Wash the cells with 100 μL 1X Assay Buffer. Remove excess 5. Analyze the stained cells by wide-field fluorescence or confocal microscopy (60X magnification recommended). Use a standard FITC filter set for imaging the lysosomes. Optionally, image the nucleus using a DAPI filter set and the RFP-tagged protein using a Texas Red filter set. D. STAINING LIVE CELLS GROWN IN SUSPENSION
1. Centrifuge cells for 5 minutes at 400 x g at room temperature (RT) 2. Carefully remove the supernatant by aspiration and dispense sufficient volume of Dual Detection Reagent (see section V-A3, page 3) to cover the dispersed cell pellet. 3. Protect samples from light and incubate for 15 to 30 minutes at 4. Wash the cells with 100 μL 1X Assay Buffer. Remove excess buffer. Resuspend cells in 100 μL 1X Assay Buffer, then apply the cells to a glass slide and overlay with a coverslip. 5. Analyze the stained cells by wide-field fluorescence or confocal microscopy (60X magnification recommended). Use a standard FITC filter set for imaging the lysosomes. Optionally, image the nucleus using a DAPI filter set and the RFP-tagged protein using a Texas Red filter set. VI. APPENDICES
A. Filter Set Selection
The selection of optimal filter sets for a fluorescence microscopy application requires matching the optical filter specifications to the spectral characteristics of the dyes employed in the analysis. Consult the microscope or filter set manufacturer for assistance in selecting optimal filter sets for your microscope. Figure 1. Absorbance and fluorescence emission spectra for Lyso-ID®
Green (panel A) and Hoechst 33342 (panel B) dyes. All spectra were deter-
mined in 1X Assay Buffer.
B. Results
Lysosomes are membrane-bound organelles involved in the degrada-tion of macromolecules and pathogens in diverse processes including endocytosis, phagocytosis and autophagy. Lysosomal morphology varies with the state of the cell and its degree of degradative activity, and the vesicles can have pieces of membranes, vacuoles, granules and even parts of mitochondria within them. They are typically spherical vesicles, ranging in size from 0.2 to 2 µm in diameter. The lumen of lysosomes and other acidic organelles is characterized by low pH generated via proton-pumping vacuolar ATPases. Lyso-ID® Green dye is selectively sequestered in acidic organelles  by a mecha-nism that likely involves protonation and retention within the membranes of the organelles. However, staining is even feasible in cells pretreated with weakly basic cell-permeant compounds, such as chloroquine. HeLa and U2OS cells treated with 300 µM chloroquine for 4 hours show a dramatic increase in lysosome-like vesicle number and volume, confirming Lyso-ID® Green dye is associated with this subcellular compartment. Thus, Lyso-ID® Green stain can be employed to highlight lysosome-like organelles under certain condi-tions, such as chloroquine drug treatment, wherein cells produce lysosome-like bodies that contain most of the degradative enzymes of the lysosome, but are not as acidic as this organelle. VII. References
1. Freundt EC, Czapiga M and Lenardo MJ (2007) “Photoconversion of Lysotracker Red to a green fluorescent molecule” Cell Res. 17(11):956-958. 2. Nadrigny F, Li D, Kemnitz K, Ropert N, Koulakoff A, Rudolph S, Vitali M, Giaume C, Kirchhoff F and Oheim M (2007) “Systematic colocali-zation errors between acridine orange and EGFP in astrocyte vesicu-lar organelles” Biophys J. 93(3):969-980. 3. Jaiswal JK, Fix M, Takano T, Nedergaard M, and Simon SM (2007) “Resolving vesicle fusion from lysis to monitor calcium-triggered lysosomal exocytosis in astrocytes” Proc Natl Acad Sci USA. 104(35):14151-14156. 4. Brunk UT, Dalen H, Roberg K and Hellquist HB (1997) “Photo- oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts” Free Radical Biology and Medicine, 23(4):616-626. 5. Michihara, Toda, Kubo, Fujiwara, Akasaki and Tsuji “Disruptive effect of chloroquine on lysosomes in cultured rat hepatocytes” (2005) Biol. Pharm. Bull. 28(6):947-951. VIII. Troubleshooting Guide
Problem Potential
some once the cells have been transferred to fresh medium. room temperature or 37°C, then vortex to dissolve all precipitate. Blue nuclear counterstain is Different microscopes, Untreated cells do not stain. The lysosomal volume is Cells do not appear healthy. Some cells require serum to Add serum to stain and wash solutions. Serum does not affect staining. Normal amounts of serum added range from 2% to 10%. The EC50 of chloroquine may Lower the dose of Chloro- be different with different cell quine, or reduce the time of
Enabling Discovery in Life Science®
c/o Covalab s.a.s. 13, Avenue Albert Einstein


Hcs 2: a quick guide to help with health costs: includes charges and optical voucher values

A QUICK GUIDE TO HELP WITH INCLUDES CHARGES AND OPTICAL April 2009 HELP WITH HEALTH COSTS CAN YOU GET FREE PRESCRIPTIONS? The list opposite will help you check whether youare entitled to free prescriptions. If you are, take proof of entitlement with you whenyou take your prescription to the pharmacy. If you forget to take proof with you, you will receivethe prescription without

Microsoft word - preliminary report.docx

SIDDHARTHA CHATTERJEE*, R G CHOWDHURY**, B KHAN*** Management of male infertility is always difficult task. In recent years booming of artificial reproductive technologies (ART) has put infertologists in front of a mil ion dol ar question whether to treat the person or the gametes. A basis andrology laboratory at present has become part and parcel of an infertility clinic. Hence treatment of m

Copyright © 2010-2014 Drug Shortages pdf